<SEC-DOCUMENT>0001493152-24-031146.txt : 20240812
<SEC-HEADER>0001493152-24-031146.hdr.sgml : 20240812
<ACCEPTANCE-DATETIME>20240812073012
ACCESSION NUMBER:		0001493152-24-031146
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240812
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240812
DATE AS OF CHANGE:		20240812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABEONA THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0000318306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				830221517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15771
		FILM NUMBER:		241194749

	BUSINESS ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103
		BUSINESS PHONE:		646-813-4701

	MAIL ADDRESS:	
		STREET 1:		6555 CARNEGIE AVE, 4TH FLOOR
		CITY:			CLEVELAND
		STATE:			OH
		ZIP:			44103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLASMATECH BIOPHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20140922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ACCESS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19960209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEMEX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ABEO="http://abeonatherapeutics.com/20240812">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_ABEO_abeonatherapeutics.com_20240812 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20240812_20240812 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0000318306 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000004" name="dei:EntityCentralIndexKey">0000318306</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="abeo-20240812.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-08-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000318306</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-12</xbrli:startDate>
        <xbrli:endDate>2024-08-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_907_edei--DocumentType_c20240812__20240812_zSzylC62BOeh"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d) OF THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of report (Date of earliest event reported): <b><span id="xdx_903_edei--DocumentPeriodEndDate_c20240812__20240812_zWXV8BEukS7i"><ix:nonNumeric contextRef="AsOf2024-08-12" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August 12, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_90B_edei--EntityRegistrantName_c20240812__20240812_zHEDRZCpIsRf"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000011" name="dei:EntityRegistrantName">ABEONA
THERAPEUTICS INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20240812__20240812_zZq4ecU5ue8a"><ix:nonNumeric contextRef="AsOf2024-08-12" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20240812__20240812_zxg0g7zV4DSh"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000013" name="dei:EntityFileNumber">001-15771</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20240812__20240812_z9Fbzjg2UJE9"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000014" name="dei:EntityTaxIdentificationNumber">83-0221517</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressAddressLine1_c20240812__20240812_zK1eJvK23E15"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000015" name="dei:EntityAddressAddressLine1">6555
Carnegie Ave</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20240812__20240812_zCgAPmZv0ms6"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000016" name="dei:EntityAddressAddressLine2">4th Floor</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20240812__20240812_zZLa1vrxP4O8"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000017" name="dei:EntityAddressCityOrTown">Cleveland</ix:nonNumeric></span>,
<span id="xdx_908_edei--EntityAddressStateOrProvince_c20240812__20240812_ziYQyqM6u6Bg"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000018" name="dei:EntityAddressStateOrProvince">OH</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20240812__20240812_z1gK6UdOBvYe"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000019" name="dei:EntityAddressPostalZipCode">44103</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>(Address
of principal executive offices) (Zip Code)</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_903_edei--CityAreaCode_c20240812__20240812_zWCdS6Z1zuX9"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000020" name="dei:CityAreaCode">(646)</ix:nonNumeric></span>
<span id="xdx_903_edei--LocalPhoneNumber_c20240812__20240812_zcnWtBvJYrH7"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000021" name="dei:LocalPhoneNumber">813-4701</ix:nonNumeric></span><br/>
</span></b>(Registrant&#8217;s telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">N/A</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20240812__20240812_z0a9ye24LwMj"><ix:nonNumeric contextRef="AsOf2024-08-12" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SolicitingMaterial_c20240812__20240812_zeleAar1DDr4"><ix:nonNumeric contextRef="AsOf2024-08-12" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20240812__20240812_zYMubpwk5kf7"><ix:nonNumeric contextRef="AsOf2024-08-12" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20240812__20240812_z0HKesbYtycj"><ix:nonNumeric contextRef="AsOf2024-08-12" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Each Class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--Security12bTitle_c20240812__20240812_zpwyTNQ92Ahc"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, $0.01 par value</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--TradingSymbol_c20240812__20240812_zoOGNbCY6bo"><ix:nonNumeric contextRef="AsOf2024-08-12" id="Fact000027" name="dei:TradingSymbol">ABEO</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span id="xdx_900_edei--SecurityExchangeName_c20240812__20240812_zehy1qY6Rhsi"><ix:nonNumeric contextRef="AsOf2024-08-12" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Markets</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20240812__20240812_zadxbgkebH3i"><ix:nonNumeric contextRef="AsOf2024-08-12" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.02. Results of Operations and Financial Condition.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 12, 2024, Abeona Therapeutics Inc. issued a press release entitled &#8220;Abeona Therapeutics&#174; Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA
to Align on Upcoming Pz-cel BLA Resubmission&#8221; regarding its financial results for
the quarter ended June 30, 2024. The full text of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm"><span style="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    release, dated August 12, 2024, entitled &#8220;Abeona Therapeutics&#174; Reports Second Quarter 2024 Financial Results and Concludes
    Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission&#8221;</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
    Therapeutics Inc.</span></td>
    <td>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td>
    <td>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 50%">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Joseph Vazzano</i></span></td>
    <td>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph
    Vazzano</span></td>
    <td>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
August 12, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2Ocq1AvGtpCKyCInodckplnRHZjfLT+ovW5VoGBiGe8+9QozEhta6RIbLMs/ghFVdKoeQ4w0ZzRW9I93uEvA3x7u2jpVx/fsDU/IMemY+jqbKC7210RaLBMJ4IsNJNAMpk3kMi70IOj0lc9MFGqdVCcoUcGSqWaNT3A4JJ/UmQ1XbV52RrSaTgByHg/yBKJQRHKhRL+KHhSxLRTDqJxAbpmftXau3Q9ORsCqx8nV2oP8bfAEArEqC -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="width: 250px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Abeona
Therapeutics<SUP>&reg;</SUP> Reports Second Quarter 2024 Financial Results and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Concludes Type A Meeting with FDA to Align on Upcoming
Pz-cel BLA Resubmission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Significant
progress addressing CMC items noted in CRL</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>BLA
resubmission remains on track for 2H 2024</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLEVELAND,
August 12, 2024 &ndash; Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the second quarter of 2024 and recent
corporate progress.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Having
completed data generation for nearly all of the Chemistry Manufacturing and Controls deliverables outlined in the Complete Response Letter
that we received in April 2024, we are on track to resubmit our Biologics License Application for pz-cel this year and, if approved,
bring a treatment option to patients with recessive dystrophic epidermolysis bullosa,&rdquo; said Vish Seshadri, Chief Executive Officer
of Abeona.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Second
Quarter and Recent Progress</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pz-cel
for RDEB</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">On
    August 8, 2024, Abeona completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss Abeona&rsquo;s forthcoming
    resubmission of its Biologics License Application (BLA) for prademagene zamikeracel (pz-cel), its investigational first-in-class,
    autologous cell-based gene therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). In pre-meeting
    communications and during the Type A meeting, Abeona shared data and reports addressing nearly all of the deficiencies noted in the
    Complete Response Letter (CRL) and gained the FDA&rsquo;s preliminary alignment pending formal review. For two remaining outstanding
    items related to sterility assays and identity assays, validation is currently ongoing under protocols that incorporate FDA feedback.
    Abeona continues to expect to resubmit the BLA in the second half of 2024. Upon acceptance of the BLA, Abeona expects the FDA to
    set a Prescription Drug User Fee Act (PDUFA) action date six months from the date of submission.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
    April 2024, Abeona received a CRL from the FDA based on the need for additional Chemistry Manufacturing and Controls (CMC) information.
    In the CRL, the FDA noted that certain additional information needed to satisfy CMC requirements must be resolved before the application
    can be approved. The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and
    the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
    May 2024, new pz-cel long-term safety data with up to 11 years of follow-up were presented during a late-breaker session at the Society
    for Investigative Dermatology (SID) Annual Meeting. In July 2024, data on wound healing at various anatomical sites after pz-cel
    treatment were presented at the Society for Pediatric Dermatology (SPD) Annual Meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>U.S.
commercial launch preparations for pz-cel</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
    continues to make progress on key commercial activities in preparation for a potential U.S. launch for pz-cel, including onboarding
    discussions with epidermolysis bullosa treatment sites, conducting medical and payer engagement, and building supply chain and enterprise
    capabilities to support the Company&rsquo;s transition to a commercial stage company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pipeline
programs</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    July 2024, Abeona announced a non-exclusive agreement with Beacon Therapeutics, under which Beacon Therapeutics will evaluate Abeona&rsquo;s
    patented AAV204 capsid for its potential use in AAV gene therapies for select ophthalmology indications.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Corporate
highlights</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    May 2024, Abeona closed a $75 million underwritten securities offering with participation from both new and existing investors.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Second
Quarter Financial Results and Cash Runway Guidance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash,
cash equivalents, short-term investments and restricted cash totaled $123.0 million as of June 30, 2024. As of March 31, 2024, cash,
cash equivalents, short-term investments and restricted cash totaled $62.7 million. Net cash used in operating activities was $12.7 million
for the three months ended June 30, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
estimates that its current cash and cash equivalents, short-term investments and restricted cash, as well as its $50 million credit facility,
are sufficient resources to fund operations into 2026, before accounting for any potential revenue from commercial sales of pz-cel, if
approved, or proceeds from the sale of a Priority Review Voucher (PRV), if awarded by the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses for the three months ended June 30, 2024 were $9.2 million, compared to $8.5 million for the same period of
2023. General and administrative expenses were $8.6 million for the three months ended June 30, 2024, compared to $5.0 million for the
same period of 2023. The increase in general and administrative expenses is primarily due to commercial and launch preparation costs.
Net income for the second quarter of 2024 was $7.4 million, including a $24.9 million gain resulting from the quarterly remeasurement
of the fair value of warrant liabilities. In the second quarter of 2023, net loss was $16.7 million, including an $8.6 million loss resulting
from the quarterly remeasurement of the fair value of warrant liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conference
Call Details</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will host a conference call and webcast on Monday, August 12, 2024, at 8:30 a.m. ET, to discuss the quarter results. To access
the call, dial 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) and Entry Code: 678762 five minutes prior to the start of
the call. A live, listen-only webcast and archived replay of the call can be accessed on the Investors &amp; Media section of Abeona&rsquo;s
website at <U>https://investors.abeonatherapeutics.com/events</U>. The archived webcast replay will be available for 30 days following
the call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Abeona Therapeutics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene
zamikeracel (pz-cel) is Abeona&rsquo;s investigational first-in-class, autologous cell-based gene therapy currently in development for
recessive dystrophic epidermolysis bullosa. The Company&rsquo;s fully integrated cell and gene therapy cGMP manufacturing facility served
as the manufacturing site for pz-cel used in its Phase 3 VIITAL&trade; trial, and is capable of supporting commercial production of pz-cel
upon FDA approval. The Company&rsquo;s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high
unmet medical need. Abeona&rsquo;s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of
devastating diseases. For more information, visit <U>www.abeonatherapeutics.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties. We have attempted
to identify forward-looking statements by such terminology as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;believe,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;potential,&rdquo; and similar words and expressions (as well as other words or expressions
referencing future events, conditions or circumstances), which constitute and are intended to identify forward-looking statements. Actual
results may differ materially from those indicated by such forward-looking statements as a result of various important factors, numerous
risks and uncertainties, including but not limited to, the timing and results of ongoing testing and other corrective actions being performed
in response to the FDA&rsquo;s identified deficiencies, which could delay the Company&rsquo;s BLA resubmission; the timing and outcome
of the FDA&rsquo;s review of our resubmission; the FDA&rsquo;s grant of a Priority Review Voucher upon approval; continued interest in
our rare disease portfolio; our ability to enroll patients in clinical trials; the outcome of future meetings with the FDA or other regulatory
agencies, including those relating to preclinical programs; the ability to achieve or obtain necessary regulatory approvals; the impact
of any changes in the financial markets and global economic conditions; risks associated with data analysis and reporting; and other
risks disclosed in the Company&rsquo;s most recent Annual Report on Form 10-K and subsequent periodic reports filed with the Securities
and Exchange Commission. The Company undertakes no obligation to revise the forward-looking statements or to update them to reflect events
or circumstances occurring after the date of this press release, whether as a result of new information, future developments or otherwise,
except as required by the federal securities laws.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
and Media Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg
Gin</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VP,
Investor Relations and Corporate Communications</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abeona
Therapeutics</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ir@abeonatherapeutics.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Statements of Operations and Comprehensive Loss</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In
thousands, except share and per share amounts)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">For the three months ended</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">June 30,</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">For the six months ended</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">June 30,</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenues:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 36%; text-align: left">License and other revenues</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">3,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">3,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,575</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,575</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,218</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,523</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,564</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">General and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,646</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,769</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,018</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Gain on operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,065</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,065</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,864</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,054</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">32,194</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">26,092</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,864</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,554</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,194</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(22,592</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,191</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">417</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,034</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">781</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,072</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(103</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,024</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(204</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of warrant and derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,927</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,629</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,626</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,364</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">224</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,215</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">386</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,618</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net Income (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,406</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(16,654</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(24,172</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(25,761</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic income (loss) per common share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.19</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.92</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.72</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.48</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Dilutive loss per common share</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.26</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.92</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.72</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1.48</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average number of common shares outstanding:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 2.5pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">40,010,481</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">18,017,874</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">33,662,908</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,464,026</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; padding-bottom: 2.5pt">Dilutive</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">51,226,715</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">18,017,874</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">33,662,908</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,464,026</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other comprehensive income (loss):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Change in unrealized gains (losses) related to available-for-sale debt securities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">50</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(30</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(68</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">34</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Comprehensive income (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,456</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(16,684</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(24,240</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(25,727</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABEONA
THERAPEUTICS INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Condensed
Consolidated Balance Sheets</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(In
thousands, except share and per share amounts)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 64%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">34,426</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">14,473</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Short-term investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,282</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">338</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,640</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,444</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,218</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">729</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,904</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,737</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,975</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,533</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,455</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">100</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">134,003</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,099</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,858</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,924</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,985</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion of long-term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,222</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion of operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,792</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion payable to licensor</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,805</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,580</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,843</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,422</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,402</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Long-term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,133</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">668</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Warrant liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">24,100</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">31,352</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,762</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,176</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stockholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Common stock - $0.01 par value; authorized 200,000,000 shares; 41,661,993 and 26,523,878 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">417</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">846,654</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">764,151</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(773,696</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(749,524</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(134</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(66</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">73,241</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,826</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">134,003</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %% \,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ***XE_C1X)CU@Z6WB*S%X)/)*[^ ^<;
M=W3.>*SG4A3MSR2OW,YU84[<\DK]SMJ*0$, 1R*6M#0**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOKT')QM;[CZ?+<P_M"#DXV:^X6BBBO6/8"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K%\6>--!\"Z6=1\0ZO9Z/9 [1->3+&I/H,GD^PK:K\Y_^"AOA
M;Q9_PLZ#6[FWO)_"K6D<5G.N6@A?'SJ<<(Q;GG&:]C*<##,,4J$Y\J_/R7F>
M+F^/GEN%>(IPYG^7F_(]R\2?%[]F'QQKGF:R='OKXM\US)I\J!CGJSA0#]2:
M][^&T7@U?#D4G@==*.C.>)-)V&-B/4KU(]^:_%K!]*^T_P#@G/X5\86OBO5]
M:\FZM/!TUF8W,P*Q7,^Y=A0'[Q4!\L.F<=Z^QS?(J>%P;J1KRM'I)W3\EMJ?
M&9/G]3%XV-.="-Y=8JS7F]]#[]HHHK\V/TT**** "BBB@ HHHH J:MJ%GI6F
M75YJ$T<%C!&SS23$!%0#DG/;%?)WC/XR?"*\U25[?P,NJL&YN=GV=7]P 0?S
M KZ?\<>$K;QUX3U/0;N1X8+Z+RS)']Y"""K>^" <=Z^.M?\ V0_'6EWCI81V
M>KV^?DEAG$9(]U?&#]"?K7SV:RQ7NJC#F7I?\#YO-Y8OW50IJ4?2[OZ'KOP=
M^.7PVFU"'2M/T5/"MW.1'&[QKL=CT7S!R/QP*^A:^/OAS^R#X@DUJUO/$]Q;
MZ;80N'>W@D\R:3!SMR/E4'UR?I7V#75ELL3*DUB(\O;2WX'5E<L5*DUB8<MM
MM+?@%%%%>N>T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45Q;17D+13
MQ)-$PPR2*&4_4&I:* /#/C/??"/X#:(OB+6_">D-?32%+2"WL(O/GDQG@XX
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MM9[>5S.G5GBZ*HX/$7E'=M:O\#B?A')X)^-FC3ZY+X'T^QO;>?R9U>W1T9\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** $9MJDGH.:^<M:_;+TK3]<EM;?0;JXM(I#&TLCA';!P2
M%QQ]#6IX@_:^\-:#XGN=*_LK4;F&VF:&6Y0*OS*<,54G)&1WQ7I7_"O?!GBF
M2WUR3P]I]U+=(MPLTML SA@&!8$<GGN*\BI6EBO=P=5)QWTN>-5K3QGNX&JD
MX[Z7*OA;PWX,\9Z?8>*;7P[9K)>()T>6V4."?4=,UW*@*  , < "FPPI;Q)%
M$BQQH JH@P% Z #L*?7ITX*"VUZVT/4ITU3CLK];*P4445H:A1110 4444 >
M>?M >)7\*_"7Q!=Q2&*>6'[-&RG#9D(3(]P"3^%> _ 75=0TWX"?%.[L[F2&
MXMK.>6!U/,;BW8[AZ'@?D*Z;]M;Q2(=(T+P_&WSS2M=R@'H%&U0?J6/_ 'S6
M#\![7?\ LV_%-\9\RTO4_*S/^->#1J^TSNE#I$^/Q59U,R<(OX8O[[-_Y'!_
M\$Y?'6I7WB[Q7HVH:E<7<4]LEU''/*7_ 'BMAFY[D']*^]:_+W]@;6!IG[0E
ME$[[4O+.X@V^K;01_*OU"K]+XHI*GF#:7Q)/]/T#A6LZN6I-_"VOU_4**P_&
MWC+2?A[X5U'Q#KER+32["+S9I,9/H%4=V)( '<D5^??Q(_X*'>-]>U">/PG:
M6GAS3 Q$3R1B>Y8>K%OE&?0+QZFO+R_*<5F3?L%HMV]CULQSC"Y6E[=ZO9+5
MGZ045^8'A?\ ;\^*NA72OJ%WI^OP9^:*\M50D>S1[<'WP:^M/@A^VYX*^+$T
M&EZF?^$4\0R$*EK>R P3L>T<W )S_"P4G/&:Z\9P_CL''GE'FBNL=?PW_ X\
M%Q%@,;)4XRY9/I+3\=OQ/H'5-+L]<TVYT_4+:.\LKE#%-!,H9'4]00:^7_&'
M_!.[P#K]\]SI.I:EX?5V+&"$K,@)/1=W('MFOJJBO)PN.Q.";>'FXW_K8]?%
M8#"XY)8BFI6_K<^1I/V8_A%^R_X?E\<^*'O/$+::RF!+L*5DF)&Q5B'!;=CJ
M<#!)X%>>ZS_P4LU=K]QI7@^SCLE;Y/M5PS2,OOM& ?I7V1\7?A5H_P 9O U]
MX8UKS([:X*R1W$) DAE4Y5USQQW!Z@D5\1:Y_P $U?&<-^ZZ/XHT*\LL_+)?
M>=!)CW54<?\ CU?6Y;BLOQB<\VGS5.G->UO*VA\?F>%S' N,,H@HT^O*E>_G
M?4]Q_9]_;@T;XO>(K;PWK.EGP_K=T2ML4D\R"9NNP$X(8@=Z^GZ^4/V=_P!A
M>T^%'BBS\4>)=9CUK6+,[[6UM(REO#)C[Y9OF<CMPN/>OJ^OGLV6!6(_V#X;
M>=K^5]3Z/)WCWAO^%#X[^5[>=M HHHKQ3W HHHH **** "BBN.^+GQ+T[X1_
M#_5?$VI,"EK'B&'.#-,>$0?4_H#6E.G*K-4X*[>B,ZE2-*#J3=DM6=C17YTM
M_P %)?'&XX\.:&!GCB7_ .*K0\._\%(_$K:]IZZWX>TM=(:=%NVM?,\U8B0&
M9<L02!DX[XQ7TSX9S)*_*OO1\M'BG+)-+G?W,_0:BJVFZE;:QI]K?V4Z7-G=
M1+-#-&<JZ,,JP/<$$59KY9IIV9]8FFKH****0PHHHH **** "BO@#]H+]LCX
MC_#OXR>)_#FCW5@FFV%PL<"RV@9@IC5N3GGDFOHC]C?XO>(?C1\+]2USQ+);
MRW\&KRV:-;Q>6OEK#"X!&>N9&YKW<3DV)PN%CBZC7*[====NAX&&SK#8K%RP
M=-/F5^FFF_4]WHHHKPCWPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X7X@?&GPK\-;N&TUF\D%W
M*N\06\9=@O8GL!7=5Q?C?X7^$?B%>0OK=E%<7L2[5=9-DFWK@X/(ZUSU_:\G
M[FW-Y['-B/;>S?L+<WGL,T/2? GQ&A@\466D:7JCS-D7LEFADW#LQ(SN'O7;
MUF^'O#NG>%=)ATW2K2.RLHONQ1CC)ZD^I/K6E5TX\L=4KO>W<NE#EC>27,][
M=PHHKR7]HKXMO\,?"2I8,!K6H$QVYX_=*/O28]L@#W(I5JT,/3=6>R%7K0P]
M.56ILB[\5/C]X<^%RO;32'4M8VY6PMV&5]/,;^$?F?:OEOQA^U)XY\3SR"UO
MQH=H?NPZ>NPCZN<MG\1]*\FO+R?4+J6YN97GGE8N\DC$LQ/4DU#7Y_BLUQ&(
M?NOECV7ZL_.,9G&)Q,K1?+'LOU9WND?'?Q]HMT)XO%6I3L#G9=SF=#_P%\BO
MK3X _'>/XL6,]EJ$<=IK]F@>2./A)X\X\Q1VP<9'N,>WP=7>_ GQ-)X5^+'A
MN[5]L<MTMK+SP4E.PY^F[/X"C+\PK4:T5*3<6[.X9=F-:A7BI2;BW9I_F?HG
M117'?%WQFG@/X?:OJQ91,L1C@#=Y&X4?U_"OT*I-4X.<MD?I52I&E!SELM3X
MM_:,\7CQA\5M6FCD\RVLR+.$^R9!_P#'BU>P?L]V^?V9_'NX<2_;_P OLB#_
M !KY5GF>XF>61B[NQ9F8Y))KZ^^!-KY/[+OB-\?ZZ#4'_P#(17_V6OC<CJ.M
MF:JO=W?XGYYEM1XC&5*LMVI,^!?V=_$2>$_CAX/U*1]D46HQHYSC*L=I'ZU^
MQ-?AQ:WDFGZC%<Q';+#*)%/H0<BOV@^&/BR+QU\/?#VO0R>:M_913,_^WM ?
M_P >!K][XOH/FHUUYK]5^I'!M=<M;#OR?Z/]#Y+_ ."E7CN:UTOPIX0@E*QW
M3R:C=*#C<$PD0/MEI#^ KX*KZP_X*1>;_P +LT+=GR?[ AV>F?M%QG^E?)]?
M59!3C2RVER]=?O9\EQ%5E5S.KS=';[D%%%%?0GS9]W?L,_M17^L:A!\.O%=X
MUW(R$:1?3MF3Y1DP,3RW RI] 1Z5]Q5^+_P=N+NT^*WA&6Q9UN1JEN%,?7!D
M4'],U^T%?D/%&"I87%1J4E;G5VO/_@G[-PKCJN+PDJ=5W<'9/R_X 4453UBX
MN;/2;Z>RM_MEY% [P6^[;YL@4E4SVR<#\:^.2N['VC=E<_.[XK?LH_&[7/BI
M?:DLLFO>?=-);ZPMZ$$2%LIP2&3 QPHXQQ7WS\.-'UGP_P"!-#TWQ#J/]K:W
M:VJ1W=YS^]<#DY/)QTR>3C/>OC[P#^TS\>=;^+5KHM_X1\RT>Z\NYT_^SVB\
MB,M@GS>VT<Y/!Q7W+7U6=UL7R4J&)Y-%=<OZ]OEH?)9%1PG/6Q&%Y[MV?-^G
M?YZA1117RA]<%%%% !1110 5^:7[=OQV_P"%A^/!X3TJXWZ#H+LDC1M\L]UT
M=N.H7[H^A(ZU]>_M<_'%?@K\+KA[*<)XCU;=9Z<H/S(2/GF^B*>#_>*U^4:B
M6\N  &FGE;MEF9B?U)-?HG"N6\TGCJBT6D?U?Z?>?FW%F9\L5@*3U>LO3HOU
M^X])_9[^"-]\=_'\.A6\C6EC'&9[V\5<^3&/ZDX ]S7'^.O!NH_#WQ=JOAW5
MHO)O]/G:&0=FQT8>S#!'L17Z@?LB_ ]/@U\,+<WD*KXAU8+=7S8Y3(^2+/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*YHQN]DEK9?UNS]?P6%PV1X3DE.RW;>EW_6R/4YYX[6&2::18H8U+O(Y 55
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M\71C7I.\9*X4445S'2%%%% 'Y'_M>?\ )R'CG_K\3_T4E?8G_!-__DA>L_\
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MN(FB<8_A8$']#7XC>(+86>O:C;@8$5Q)'CZ,17ZCPGB95J%3#5-5&UO1WT_
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M)GT7UO"44H.I%6\T>O45XRW[8?P@7&?&EH?I%*?_ &6I$_:]^$,AP/&MD/\
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M1I#\L-ST ]@XX^N*_1ROQO-LOEEN*E2^R]5Z?\#8_:LGS&.9X2-;[2TEZ_\
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MMY:VNDD?/_PU^"_C/XO?VC_PB.BOK']G^7]JVSQ1^7YF[9]]ESG8W3TKMO\
MAB_XS?\ 0E3?^!MM_P#':]E_X)G:PD'BSQOI98"2ZLK:X5>Y$;NI/_D4?G7W
M_7T6;<0XK+\9+#TX1<5:U[WU2\^Y\UD_#F$S'!PQ%2<E)WO9JVC]'T/R;_X8
MO^,W_0E3?^!MM_\ ':/^&+_C-_T)4W_@;;?_ !VOUDHKQ_\ 6[&_\^X?<_\
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MPF^$>N:G/,JWUU ]G8PYPTDSJ0,?[H)8_3WK\B(HY=0O$C0&6>:0*!W9B?\
M&NI^)GQ:\5_%[7!JGBG5I=2G0%88L!(H%/\ "B#A>WN<<DU]%?L3_LP:AXL\
M26/COQ'9M;>';%A-8PSI@WLH^ZP!_P"68/.>_:ON\%AZ?#N!G5KR3D]7YOHD
M?G^.Q-7B7'PI8>+45HO)=6S[E^#?@_\ X0'X6>%] 9#')96$:2J1@K(1N<?]
M],U=E117Y'4J2JSE4ENW?[S]CITXTH1IQV2M]P5\C_\ !1?X>R:]\-M)\46T
M7F2Z)<[)SCE89<*3_P!]A/SKZXK.\1>'[#Q7H.H:-JENMUI]] ]O/"W1D88(
M_6NS+\4\#BH8A?9?X=?P.+,,(L=A:F'?VE^/3\3\D_V9?BRGP9^,&D:]<LPT
MN3=9WX09/D28R?\ @+!'QWVU^N>F:G::UI]M?V%Q'=V=Q&)89X6#(ZD9!!'4
M5^3/[1'[-OB#X#^))EE@FO\ PS/(38ZLJ94J3PDA'"R#T. >H[@4OA+^TSX_
M^#$8MM U?S=+W;CI=^GG6^>^!D,G_ ",U^DYME4,[A#&8.:O;Y-?HT?F.49O
M/(ISP6-@^6_S3_5,_7VBO@?0_P#@IEJL,:C6? UG>/W>QOW@'UPR/_.NEB_X
M*9:(RKYG@>_0]]M^C8_\<%?%2X=S.+M[*_S7^9]S#B3*YJ_M;>J?^1]IT5\:
M+_P4N\,E?F\&ZH#Z"ZC/]*AF_P""F.@JI\KP1J#MV#WR*/\ T UG_8&9_P#/
ME_>O\S3_ %ARO_G\ON?^1]HUSOQ"\9V/P]\$ZSXAU"=+>VL+9Y=TAP&?'R*/
M=FP!]:^*M>_X*9:G-&RZ+X&M+1\?+)?W[3C/J55$_G7SA\7OVB/''QMFC'B3
M5,V$3;XM-LT\JVC;UVYRQ]V)(SUKU,'POC*E1/$I1CUU3?RM<\G&\5X*E3:P
MS<Y=-&E\[V([S]H;XB7%Y/*GB_5XTDD9@@N6XR<XK],/V59M9O/@/X8O=>O+
MB^U.\CDN'ENF+/M:1MF2?]D#\Z_//]FO]FO7/CEXGMI6MI;/PK;RAKW4G7"D
M \QQY^\YZ<=.^*_5W3=.M]'TZUL+.)8+2UB6"&)>B(H"JH^@ KOXHKX:,882
MBES)W=DM.R.#A3#XJ4IXNO)\K5E=O7NRS1117YX?HY\<?\%(? <NJ>"?#_BN
M"-G_ +)N6M;C:.%CEQAC_P #51_P*OBGX-?$2;X4_$[P_P"*8E9UL+@--&O5
MXF!21?J59L>^*_8/QEX1TWQYX6U/P_J\/VC3M0@:"9.AP1U![$=0>Q%?DM\=
MO@#XC^!/BB:PU2W>XTF5S]AU6-#Y-RG4#/\ "X'53R,'&1@U^H<-8VEB,*\O
MK/57LNZ>_P"I^5<3X&MAL7',J*T=KOM);??H?K?X9\3:;XPT&RUG2+J.]TZ\
MB$L,T9R""/Y^U:E?CW\(_P!HOQS\$Y67PYJO_$O=MTFF7B^;;.?7;G*GW4@U
M]*^'_P#@IG<I"B:YX%BFE_BFT_4#&OX(Z-_Z%7@XSA?&49OZNN>/35)_.]OP
M/?P?%>"K07UA\DNNC:^5K_B?=]%?&T/_  4M\+MCS?!^JH?]FXC;^@J.X_X*
M7^'5SY/@O4I/]^[C7_V4UYO]@9G_ ,^7]Z_S/4_UARO?VR^Y_P"1]FT5\07'
M_!3>S7/D?#V>3_KIJX3^4)KE?$7_  4L\4W<+KHGA+2M-<\![R>2Y*^^%\OF
MMH<-YG)ZT[>K7^9C/B;*X*ZJW]$_\C[F^(/C[1_AGX2U#Q%KETMK8V<9;YB
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M;F216*CWQD_\!-?07[=OP+OOB?X%L_$&AVSW>MZ!O9K:(9>>W;&\*/XF4J&
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M!1R_+:F'4N9I2OZM?\,?FV,QTLQS2GB''E3<;>B?^=S]AJ***_%#]S"BBB@
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MF[M+(68EF8Y)/)-=-\2/'E[\1_%U]K5Z2#,^(H<Y$48X5!]!^N37OW[./[.
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M/4OR;_XFJ=Q^U[-:WD5I-X.O(KJ492%W(=LG' V\]#7TC7S)\:R?^&H? /\
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MBG1V]+R(_P#CXK]*_P!O#X8_\)Y\%9M6MH?,U/P[+]MC*C+&$X691[8VN?\
MKG7YH>'&V>(-,;TN8S_X\*_:\CQGUW+X\S]Z/NOY;?@?AN?8+ZCF,N5>[+WE
M\]_QN?MS9MNLX&]8U/Z5-5326WZ79MZPH?\ QT5;K\5>Y^XQV04444AE'6M#
MT_Q)I=SINJV4&H:?<H8YK:YC#QR*>Q!X-?#GQT_X)[W,-Y-J_P -9U>W8EVT
M6[DPT?\ URD/4>S<^_:OO&BO4P.98G+I\U"6G5='\CRLPRS#9E#EQ$=5L^J^
M9Y3^S/#X[L?A786'Q!M6M]:LV:!&DE$DDD*\(7()YQQG/.*]6HHKBKU?;U95
M;)7=[+8[J%+V%*-*[?*K7>_S"BBBL#<*^9/C7_R=!X!_ZX6__H^6OINOF3XU
M_P#)T'@'_KA;_P#H^6O)S+^#'_%'\SQ\T_@Q_P 4?S/INBBBO6/8"BBB@#Y+
M^.&@R^)_VE=&TN&^ETV2YMX(UNH"=\>=W(Y%=G_PS#K/_11=8_[Z?_XNL3XA
M?\G<>%_]RW_]GKZ<KYW#X6CB*M:517?,^K_0^:PN$HXBK7E45VI/JU^3/G[_
M (9AUG_HHNL?]]/_ /%TO_#,.L_]%%UC_OI__BZ^@**[_P"S<-_+^+_S/1_L
MS"_RO[W_ )GR3\!-#D\-_M(:YIDMY)J$EM:S(US,26DY3DU];5\O_"__ ).Q
M\5?]<9_YI7U!6.5Q4:,XKI*1AE$5&C.*V4I!7"?'3_DD?BG_ *\9/Y5W=<)\
M=/\ DD?BG_KQ?^5>AB?X$_1_D>CBOX%3T?Y'SO\ !'X&7WC[P';ZM!XLOM(C
M::2/[+!NVC:W7AAUKOO^&6-4_P"B@:I_X]_\761^SC\8O"?@KX96VF:QJBVE
MZMQ,YC*,< MQT%>H?\-'_#__ *#J_P#?I_\ "OG\+2P#H0=22YK*_O?\$^<P
ME'+I8>#J27-97][_ ()PW_#+&J?]% U3_P >_P#BZ]5^%_@.?X=^'9=,N-7G
MUIWN6G^T7&=P!51MY)X&W]:P_P#AH_X?_P#0=7_OT_\ A72>"_B5X>^(#7:Z
M%?B]:T"&;"E=N[.WJ/\ 9/Y5Z>'A@H5$Z,ES?XK_ *GJX:G@:=1.A)<W^*_Z
MG44445ZQ[!\S_MN?\@'PO_U]2_\ H J_#<?'_P F/8-,V;1M_=Q=,?2J'[;G
M_(!\+_\ 7U+_ .@"OI*S_P"/2#_<7^5?/JA[;&UO?<;<NSMT/G(X?V^.K^^X
MVY=G;H?/_P!H_:!]-,_[]Q?X5#>7'[0?V:0)_9X;'!BCAW?AD8KZ,HKL^HO_
M )_3^\[?[/?_ #^G_P"!?\ ^6/V;;+1[KXDZK<:]-J#^/8O,,D=_C:#G#D$<
MENWT/%?4]?,5E"L'[9VH"-=H:)6./4VR$_K7T[6>6>[3G3_EDUZ^;\S/*ERT
MIT_Y9-7[^;\PHHKS_P"-WQ,B^&/@>YOU93J=QF"RB/5I"/O8]%'/Y>M>G4J1
MHP=2>R/5JU8T8.I-V2/'/C]XLD^)GQ TWX=Z7>1P6,$P:_N&D"IO')R3_<'Z
MFO?O#<WAOPKH-CI%AJ-C%:6<0BC7[0G;OUZDY/XU\^_"7]F:S\9>%(_$'BBY
MO8]0U)C<(L;;3Y9Y!;(ZMU_&NU_X9%\(?\_>I?\ ?T?X5X.&^M\TL3[--S[N
MUET6Q\[A?KG-+%>S3<^[M9=%L==\6M!\/?$[P3>Z-+JFGK<X\VTF-PG[N91\
MIZ]#R#[$UPG[+/Q*EU#3;GP7J\O_ !-=()6 L^3)"#C:#WVGCZ8J[_PR+X0_
MY^]2_P"_H_PKSKXI?".7X"ZAHOC/PI-<S06TP6Z69LD$GC.!]UAE:5:6)I55
MBY4TDM)6=[K[N@J\L51JK&2II):2L[W7W=-SZWHK$\%^+++QQX9L-:L'#074
M88KGE&_B4^X-;=?11DII2CLSZ:,E.*E%W3,SQ/\ \BWJW_7I-_Z :^/O@%JW
MQ&T[1=67P9IEG?6C7*F=KC&0^W@#+#M7V#XG_P"1;U;_ *])O_0#7A'[%_\
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M:_\  G_F><J&5M:37_@;_P SS+4?@G\4?".ESW>D?$2[OWMT,OV:2610V!G
M#,PS7<_LY_%J_P#B9X=O(M9"?VOIT@CED10OFJ1PV!P#P0:SO%W[57@JQT6\
M73;B?4[YHV2*&.%E4L1@98X&,UD_LA^%=0T[0]9UV_@>V74I5\A77&Y1DEN>
MV3^E11=.&+A#"SO%I\RO=>1G1E2IXR%/"3<HM/F5VTNQ]"4445]&?3A1110
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M  ]E;+>%[//LSC^35Z#16,Z-*H[SBGZHPG0I5'><$WYI'GR_ #X>IT\+V?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>abeo-20240812.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamI6bP9z5Z8iekhvWB9bbl6Tyklm9t1byrlHBS2oaUD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ABEO="http://abeonatherapeutics.com/20240812" elementFormDefault="qualified" targetNamespace="http://abeonatherapeutics.com/20240812">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abeonatherapeutics.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="abeo-20240812_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abeo-20240812_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>abeo-20240812_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>abeo-20240812_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://abeonatherapeutics.com/role/Cover" xlink:href="abeo-20240812.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abeonatherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ Q3L,6:K$(A8S 0  (@(   \
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M4$L! A0#%     @ Q3L,60PX=UCN    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ Q3L,69E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " #%.PQ9D+D3B6($   ;$0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ Q3L,69^@&_"Q @  X@P
M  T              ( !I0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #%
M.PQ9EXJ[',     3 @  "P              @ &!#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " #%.PQ9JL0B%C,!   B @  #P              @ %J$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ Q3L,620>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ Q3L,6660>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-24-031146-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-031146-xbrl.zip
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M"6KRD!3/@_=0 NK=PM)CN\D,( X(G6Z' $$R"#6C?((T9Q$7S[SVN,.,;^4
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MZV\#H]TR\Z8F-6D:%!H09V_Q"Q!XJ +5ZOA0F[%\7LQ3#XVK;&X\>EH\8GD
M;[=9JF90:0R^"MX9Y/CVPH &&#<9.B("0F^ 3>B&0QZ)\M /J A&M6A/YV?I
M(0L@B3_O[\D#$>J]@R7999_ECIXZSC &Q+H^>QO<'/-DKC<P" C?ZA8ZU4M1
MO0*T4L^(E56@WU0E**_%]OOE]4W7\I/<K#?)OU8X)7++?P%02P,$%     @
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M\$T1H#@T/JAO% )CJ C3>>= UXT]X-Y96WSC?KGWLMHC_P-02P,$%     @
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M)M<.FA+BB%Q1X65-+I=N<OF6?1O32$ G'\^N+_X\Q5^^W'^].OU_4$L#!!0
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MK3()@:?!\%/[::Q7=Z6C)ND#N"5CE6(X5@GC3)8+J?/9V&32U1N->7_:06/
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M7D!+I!<F\L*?>;R(0N[/&RXK([5J@F Y=3RIWF#98JSPFZYJV,&(W6>*MLA
M)BH+TYDZ0F3*0MP&?T<Z8B])1ZK_:I7?<@[C]Z\,29N5H4^Q,O3V28:U7/%9
MZ]4JN=QNG%Q5.C>M-7YYVEJG;*[]73A!LM8&NZG9?E+MI:GBF-U%JJN/D8)=
MMB.(9[W]5Y@!&ID@"NQ @>F]5$@F?:QWD3SFRRD\I>M78%EOUX V'!QVG;YI
M _'J)KGT<9)+ )_Q>)B47DWZ*OO;<_H]+WUV33+.V9N;&C]U[X3N==S^C;VQ
MK&KGW_GDV:L)S+TWA4''Q#EY'T)VJ^R.HW'I?9*K*W5NM'*&9CBM9R8E5A]]
MQ4]/V# /,EIL/OOSRY$=MBEYA'RPI( G(4[)1$I_HH3X&<F/*:)J7R/>6X.F
MF;HFO^_;?K&L-L>RWI5X]@[?TNS6L37EY;5II^P^:O(5-%I"%^PBXDT6ZI=9
MJ#5*%*WUF'SFX$:;./N(S]-HI([V4:/&_[@5"D>W_&B0=V$R$PYO1LY&QW=J
M_;QW7_G2DC.5[NA.:BH/8F5XXEC5\W&U89BJ<F_I1NOTYUWWHO.W.?R6_VJ>
M'&DGI/!W\8OY5.\[>+?5D"\N::;7/_ZJGIOD2^Y1^/G4^E9L%+-N?5C)CO9<
MZ<[Z.LIT:>TFT[@D@Q]_WSW(Y]4]211:^.+H\BS7H%=G5Y5+ZSY[?ZGM"8WF
MG: KQ<OCDP?U:U4Q;Y23]L,W?-7)5G)G9YF;P1?QN_PU+[7L-N[TCL:GO<SX
MZ/SL2^OTO-^Z^/O\M-\>7;0ZM8>S446V!EWG.W:S7XK-%JT^C K&5\F\+LC=
M2KUBUQ^J7H]D9%,=L\^^,]#+_P-02P$"% ,4    " #%.PQ90N0E1BT#   !
M#   $0              @ $     86)E;RTR,#(T,#@Q,BYX<V102P$"% ,4
M    " #%.PQ95"H?XOX*  " A@  %0              @ %< P  86)E;RTR
M,#(T,#@Q,E]L86(N>&UL4$L! A0#%     @ Q3L,69.3=:9<!P  Z5<  !4
M             ( !C0X  &%B96\M,C R-# X,3)?<')E+GAM;%!+ 0(4 Q0
M   ( ,4[#%G<FDJ$-QT  -TR 0 *              "  1P6  !E>#DY+3$N
M:'1M4$L! A0#%     @ Q3L,6=+J_4P:$P  J)8   L              ( !
E>S,  &9O<FTX+6LN:'1M4$L%!@     %  4 -@$  +Y&      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abeo-20240812.xsd" xlink:type="simple"/>
    <context id="AsOf2024-08-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000318306</identifier>
        </entity>
        <period>
            <startDate>2024-08-12</startDate>
            <endDate>2024-08-12</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-08-12" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-08-12" id="Fact000004">0000318306</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-08-12" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-08-12" id="Fact000010">2024-08-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-08-12" id="Fact000011">ABEONA THERAPEUTICS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-08-12" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-08-12" id="Fact000013">001-15771</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-08-12" id="Fact000014">83-0221517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-08-12" id="Fact000015">6555 Carnegie Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-08-12" id="Fact000016">4th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-08-12" id="Fact000017">Cleveland</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-08-12" id="Fact000018">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-08-12" id="Fact000019">44103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-08-12" id="Fact000020">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-08-12" id="Fact000021">813-4701</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-08-12" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-08-12" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-08-12" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-08-12" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-08-12" id="Fact000026">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-08-12" id="Fact000027">ABEO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-08-12" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-08-12" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140110449593248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 12, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 12,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABEONA
THERAPEUTICS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000318306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-0221517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555
Carnegie Ave<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cleveland<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">44103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">813-4701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABEO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abeonatherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abeo-20240812.xsd</File>
    <File>abeo-20240812_lab.xml</File>
    <File>abeo-20240812_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "ABEO",
   "nsuri": "http://abeonatherapeutics.com/20240812",
   "dts": {
    "schema": {
     "local": [
      "abeo-20240812.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "abeo-20240812_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abeo-20240812_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://abeonatherapeutics.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-08-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://abeonatherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
